New Strategies to Enhance Smoking Cessation

Recruiting now · Not applicable

Conditions studied: Smoking Cessation

In brief

The study goal is to get feedback on ways researchers can communicate complex research findings on smoking cessation to better inform patients' decisions to use medication and/or quit smoking. This will help researchers and clinicians to provide effective, easy-to-implement treatments designed to address tobacco-related health disparities in Black and other racial/ethnic subgroups. It will also help improve health literacy to change misperceptions and mistrust on uptake of varenicline and other medication for quitting smoking. A professionally made video will explain research findings relevant for varenicline's mechanisms and outcomes relative to other treatment options. There are 2 parts to this study: * Part 1: Focus Group to help develop the educational tool intervention * Part 2: Randomized portion of study. In this part of the study, participants will be randomized (like flip of coin) to take part in receive the experimental educational intervention or usual methods to help stop smoking. Participants in either arm can choose to receive varenicline and it will be provided as part of study.

Key facts

Study ID

NCT06751927

Run by

University of Chicago

People needed

94

Starts

2025-04-24

Expected to finish

2030-12-01

Last updated by the study team

2025-06-11

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients must smoke at least 10 cigarettes/day and do not currently use a smoking cessation medication.
• Ages 18-75.
• Agree to complete surveys and measures within study.
• Ability to understand English and the willingness to sign a written informed consent document.

You may not qualify if…

• Patients who are receiving any other smoking cessation medications.
• Patients who are pregnant and/or lactating.
• Patients with psychiatric contraindications that can prevent adherence to protocol or use of intervention tools in study. For inclusivity on trial, psychiatric contraindications and ability for patient to participate in trial will be assessed on an individual basis by study investigator.
• Patients who have a contraindication with varenicline.

Where it is running

• University of Chicago — Chicago, Illinois, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.